LMECA Co. Ltd.

LMECA Co. Ltd. specializes in the LMECA A-1000 Medical Suction System, a device intended for clinical use to aspirate fluids from patients’ airways or body cavities during medical procedures. This product is designed to assist healthcare professionals in maintaining clear airways or draining bodily fluids safely during treatments.

LMECA Co. Ltd. is headquartered in South Korea. The company’s location is relevant for understanding its regulatory framework and manufacturing operations, though it does not directly impact the classification or authorization status of its devices.

The LMECA A-1000 Medical Suction System falls under Class IIa classification under the EU Medical Device Regulation. This classification is determined by factors like the device’s intended purpose, potential risks, and the level of intervention it involves—here, moderate risk due to its role in airway management and fluid removal.

Yes, LMECA Co. Ltd.’s devices are registered in the eudamed database, which is the European Union’s central registry for medical devices. Listing in eudamed is a requirement for manufacturers placing devices on the EU market, ensuring transparency and traceability of their products.

The classification of LMECA Co. Ltd.’s devices, such as the LMECA A-1000, is based on criteria outlined in the EU Medical Device Regulation (MDR). Factors like the device’s purpose (e.g., aspirating fluids from airways), its invasiveness, and the potential health risks it poses (e.g., obstruction or infection) are evaluated. Class IIa indicates a moderate risk level, requiring compliance with specific design controls, clinical evaluations, and post-market surveillance to ensure safety and performance.